APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Injection General Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Intravenous Injection General Anesthesia Drugs Market Outlook and Growth Opportunities 2026

Report ID 174004290422 December 2025209 pages

Choose your research edition.

Industry ResearchIntravenous Injection General Anesthesia Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Injection General Anesthesia Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Intravenous Injection General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Injection General Anesthesia Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Injection General Anesthesia Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Intravenous Injection General Anesthesia Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Intravenous Injection General Anesthesia Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Intravenous Injection General Anesthesia Drugs market include Aspen Pharma, Hikma Pharmaceuticals, Maruishi, Maruishi, Piramal, AstraZeneca, AbbVie, Baxter Healthcare and B.Braun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intravenous Injection General Anesthesia Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Injection General Anesthesia Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Injection General Anesthesia Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Injection General Anesthesia Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Injection General Anesthesia Drugs Segment by Company

Aspen Pharma

Hikma Pharmaceuticals

Maruishi

Maruishi

Piramal

AstraZeneca

AbbVie

Baxter Healthcare

B.Braun

Fresenius-Kabi

China National Medicines Guorui Pharmaceutical Co.,Ltd.

Hengrui

Nhwa

Lunan Pharmaceutical Group Corporation

Xi'an Libang

Yichang Humanwell

Intravenous Injection General Anesthesia Drugs Segment by Type

Propofol

Sevoflurane

Remifentanil

Etomidate

Isoflurane

Other

Intravenous Injection General Anesthesia Drugs Segment by Application

Hopitals

Clinics

Others

Intravenous Injection General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Intravenous Injection General Anesthesia Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Intravenous Injection General Anesthesia Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intravenous Injection General Anesthesia Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Intravenous Injection General Anesthesia Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Injection General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Injection General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Injection General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Injection General Anesthesia Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intravenous Injection General Anesthesia Drugs industry.

Chapter 3: Detailed analysis of Intravenous Injection General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Intravenous Injection General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Intravenous Injection General Anesthesia Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intravenous Injection General Anesthesia Drugs Industry Trends Table 2. Intravenous Injection General Anesthesia Drugs Industry Drivers Table 3. Intravenous Injection General Anesthesia Drugs Industry Opportunities and Challenges Table 4. Intravenous Injection General Anesthesia Drugs Industry Restraints Table 5. Global Intravenous Injection General Anesthesia Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intravenous Injection General Anesthesia Drugs Revenue Share by Company (2021-2026) Table 7. Global Intravenous Injection General Anesthesia Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Intravenous Injection General Anesthesia Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Intravenous Injection General Anesthesia Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Intravenous Injection General Anesthesia Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Intravenous Injection General Anesthesia Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Intravenous Injection General Anesthesia Drugs Company, Product Type & Application Table 13. Global Intravenous Injection General Anesthesia Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Injection General Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Propofol Table 18. Significant Companies of Sevoflurane Table 19. Significant Companies of Remifentanil Table 20. Significant Companies of Etomidate Table 21. Significant Companies of Isoflurane Table 22. Significant Companies of Other Table 23. Global Intravenous Injection General Anesthesia Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Intravenous Injection General Anesthesia Drugs Sales Volume by Type (2021-2026) & (k units) Table 25. Global Intravenous Injection General Anesthesia Drugs Sales Volume by Type (2027-2032) & (k units) Table 26. Global Intravenous Injection General Anesthesia Drugs Sales Volume Share by Type (2021-2026) Table 27. Global Intravenous Injection General Anesthesia Drugs Sales Volume Share by Type (2027-2032) Table 28. Global Intravenous Injection General Anesthesia Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Intravenous Injection General Anesthesia Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Intravenous Injection General Anesthesia Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Type (2021-2026) Table 32. Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Hopitals Table 34. Significant Companies of Clinics Table 35. Significant Companies of Others Table 36. Global Intravenous Injection General Anesthesia Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Intravenous Injection General Anesthesia Drugs Sales Volume by Application (2021-2026) & (k units) Table 38. Global Intravenous Injection General Anesthesia Drugs Sales Volume by Application (2027-2032) & (k units) Table 39. Global Intravenous Injection General Anesthesia Drugs Sales Volume Share by Application (2021-2026) Table 40. Global Intravenous Injection General Anesthesia Drugs Sales Volume Share by Application (2027-2032) Table 41. Global Intravenous Injection General Anesthesia Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Intravenous Injection General Anesthesia Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Intravenous Injection General Anesthesia Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Application (2021-2026) Table 45. Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Application (2027-2032) Table 46. Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2021-2026) & (k units) Table 48. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2021-2026) Table 49. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2027-2032) & (k units) Table 50. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2027-2032) Table 51. Global Intravenous Injection General Anesthesia Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Intravenous Injection General Anesthesia Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Region (2021-2026) Table 54. Global Intravenous Injection General Anesthesia Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Region (2027-2032) Table 56. Global Intravenous Injection General Anesthesia Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 57. Global Intravenous Injection General Anesthesia Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 58. Global Intravenous Injection General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Intravenous Injection General Anesthesia Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 61. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 62. Global Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 63. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2027-2032) Table 64. Global Intravenous Injection General Anesthesia Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Intravenous Injection General Anesthesia Drugs Sales Value Market Share by Country (2021-2026) Table 66. Global Intravenous Injection General Anesthesia Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Intravenous Injection General Anesthesia Drugs Sales Value Market Share by Country (2027-2032) Table 68. Aspen Pharma Company Information Table 69. Aspen Pharma Business Overview Table 70. Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio Table 72. Aspen Pharma Recent Development Table 73. Hikma Pharmaceuticals Company Information Table 74. Hikma Pharmaceuticals Business Overview Table 75. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio Table 77. Hikma Pharmaceuticals Recent Development Table 78. Maruishi Company Information Table 79. Maruishi Business Overview Table 80. Maruishi Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 82. Maruishi Recent Development Table 83. Maruishi Company Information Table 84. Maruishi Business Overview Table 85. Maruishi Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 87. Maruishi Recent Development Table 88. Piramal Company Information Table 89. Piramal Business Overview Table 90. Piramal Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio Table 92. Piramal Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio Table 97. AstraZeneca Recent Development Table 98. AbbVie Company Information Table 99. AbbVie Business Overview Table 100. AbbVie Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio Table 102. AbbVie Recent Development Table 103. Baxter Healthcare Company Information Table 104. Baxter Healthcare Business Overview Table 105. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio Table 107. Baxter Healthcare Recent Development Table 108. B.Braun Company Information Table 109. B.Braun Business Overview Table 110. B.Braun Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio Table 112. B.Braun Recent Development Table 113. Fresenius-Kabi Company Information Table 114. Fresenius-Kabi Business Overview Table 115. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 117. Fresenius-Kabi Recent Development Table 118. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information Table 119. China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview Table 120. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio Table 122. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Development Table 123. Hengrui Company Information Table 124. Hengrui Business Overview Table 125. Hengrui Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio Table 127. Hengrui Recent Development Table 128. Nhwa Company Information Table 129. Nhwa Business Overview Table 130. Nhwa Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio Table 132. Nhwa Recent Development Table 133. Lunan Pharmaceutical Group Corporation Company Information Table 134. Lunan Pharmaceutical Group Corporation Business Overview Table 135. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio Table 137. Lunan Pharmaceutical Group Corporation Recent Development Table 138. Xi'an Libang Company Information Table 139. Xi'an Libang Business Overview Table 140. Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio Table 142. Xi'an Libang Recent Development Table 143. Yichang Humanwell Company Information Table 144. Yichang Humanwell Business Overview Table 145. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio Table 147. Yichang Humanwell Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Intravenous Injection General Anesthesia Drugs Distributors List Table 151. Intravenous Injection General Anesthesia Drugs Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Intravenous Injection General Anesthesia Drugs Product Image Figure 2. Global Intravenous Injection General Anesthesia Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Intravenous Injection General Anesthesia Drugs Sales (2021-2032) & (k units) Figure 5. Global Intravenous Injection General Anesthesia Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Intravenous Injection General Anesthesia Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Propofol Image Figure 10. Sevoflurane Image Figure 11. Remifentanil Image Figure 12. Etomidate Image Figure 13. Isoflurane Image Figure 14. Other Image Figure 15. Global Intravenous Injection General Anesthesia Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Intravenous Injection General Anesthesia Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Intravenous Injection General Anesthesia Drugs Sales Volume Share by Type (2021-2032) Figure 18. Global Intravenous Injection General Anesthesia Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Intravenous Injection General Anesthesia Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Type (2021-2032) Figure 21. Hopitals Image Figure 22. Clinics Image Figure 23. Others Image Figure 24. Global Intravenous Injection General Anesthesia Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Intravenous Injection General Anesthesia Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Intravenous Injection General Anesthesia Drugs Sales Volume Share by Application (2021-2032) Figure 27. Global Intravenous Injection General Anesthesia Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Intravenous Injection General Anesthesia Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Application (2021-2032) Figure 30. Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Intravenous Injection General Anesthesia Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. North America Intravenous Injection General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Intravenous Injection General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. South America Intravenous Injection General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Intravenous Injection General Anesthesia Drugs Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Intravenous Injection General Anesthesia Drugs Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Propofol
  • Sevoflurane
  • Remifentanil
  • Etomidate
  • Isoflurane
  • Other
Applications
  • Hopitals
  • Clinics
  • Others
Companies covered
  • Aspen Pharma
  • Hikma Pharmaceuticals
  • Maruishi
  • Maruishi
  • Piramal
  • AstraZeneca
  • AbbVie
  • Baxter Healthcare
  • B.Braun
  • Fresenius-Kabi
  • China National Medicines Guorui Pharmaceutical Co.,Ltd.
  • Hengrui
  • Nhwa
  • Lunan Pharmaceutical Group Corporation
  • Xi'an Libang
  • Yichang Humanwell

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Intravenous Injection General Anesthesia Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Intravenous Injection General Anesthesia Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Intravenous Injection General Anesthesia Drugs Market Dynamics
  1. 2.1 Intravenous Injection General Anesthesia Drugs Industry Trends
  2. 2.2 Intravenous Injection General Anesthesia Drugs Industry Drivers
  3. 2.3 Intravenous Injection General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 Intravenous Injection General Anesthesia Drugs Industry Restraints
3 Intravenous Injection General Anesthesia Drugs Market by Company
  1. 3.1 Global Intravenous Injection General Anesthesia Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Intravenous Injection General Anesthesia Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Intravenous Injection General Anesthesia Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Intravenous Injection General Anesthesia Drugs Company Ranking (2024-2026)
  6. 3.6 Global Intravenous Injection General Anesthesia Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Intravenous Injection General Anesthesia Drugs Company Product Type and Application
  8. 3.8 Global Intravenous Injection General Anesthesia Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Intravenous Injection General Anesthesia Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Intravenous Injection General Anesthesia Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Intravenous Injection General Anesthesia Drugs Market by Type
  1. 4.1 Intravenous Injection General Anesthesia Drugs Type Introduction
  2. 4.1.1 Propofol
  3. 4.1.2 Sevoflurane
  4. 4.1.3 Remifentanil
  5. 4.1.4 Etomidate
  6. 4.1.5 Isoflurane
  7. 4.1.6 Other
  8. 4.2 Global Intravenous Injection General Anesthesia Drugs Sales Volume by Type
  9. 4.2.1 Global Intravenous Injection General Anesthesia Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Intravenous Injection General Anesthesia Drugs Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Intravenous Injection General Anesthesia Drugs Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Intravenous Injection General Anesthesia Drugs Sales Value by Type
  13. 4.3.1 Global Intravenous Injection General Anesthesia Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Intravenous Injection General Anesthesia Drugs Sales Value by Type (2021-2032)
  15. 4.3.3 Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Type (2021-2032)
5 Intravenous Injection General Anesthesia Drugs Market by Application
  1. 5.1 Intravenous Injection General Anesthesia Drugs Application Introduction
  2. 5.1.1 Hopitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Injection General Anesthesia Drugs Sales Volume by Application
  6. 5.2.1 Global Intravenous Injection General Anesthesia Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Injection General Anesthesia Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Intravenous Injection General Anesthesia Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Intravenous Injection General Anesthesia Drugs Sales Value by Application
  10. 5.3.1 Global Intravenous Injection General Anesthesia Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous Injection General Anesthesia Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Intravenous Injection General Anesthesia Drugs Sales Value Share by Application (2021-2032)
6 Intravenous Injection General Anesthesia Drugs Regional Sales and Value Analysis
  1. 6.1 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Injection General Anesthesia Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Intravenous Injection General Anesthesia Drugs Sales by Region (2027-2032)
  5. 6.3 Global Intravenous Injection General Anesthesia Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Intravenous Injection General Anesthesia Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Intravenous Injection General Anesthesia Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Intravenous Injection General Anesthesia Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Intravenous Injection General Anesthesia Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Intravenous Injection General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Intravenous Injection General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Intravenous Injection General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Intravenous Injection General Anesthesia Drugs Sales Value Share by Country, 2025 VS 2032
7 Intravenous Injection General Anesthesia Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Intravenous Injection General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intravenous Injection General Anesthesia Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032)
  6. 7.4 Global Intravenous Injection General Anesthesia Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Intravenous Injection General Anesthesia Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Intravenous Injection General Anesthesia Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Intravenous Injection General Anesthesia Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Intravenous Injection General Anesthesia Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Intravenous Injection General Anesthesia Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aspen Pharma
  2. 8.1.1 Aspen Pharma Company Information
  3. 8.1.2 Aspen Pharma Business Overview
  4. 8.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio
  6. 8.1.5 Aspen Pharma Recent Developments
  7. 8.2 Hikma Pharmaceuticals
  8. 8.2.1 Hikma Pharmaceuticals Company Information
  9. 8.2.2 Hikma Pharmaceuticals Business Overview
  10. 8.2.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio
  12. 8.2.5 Hikma Pharmaceuticals Recent Developments
  13. 8.3 Maruishi
  14. 8.3.1 Maruishi Company Information
  15. 8.3.2 Maruishi Business Overview
  16. 8.3.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
  18. 8.3.5 Maruishi Recent Developments
  19. 8.4 Maruishi
  20. 8.4.1 Maruishi Company Information
  21. 8.4.2 Maruishi Business Overview
  22. 8.4.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
  24. 8.4.5 Maruishi Recent Developments
  25. 8.5 Piramal
  26. 8.5.1 Piramal Company Information
  27. 8.5.2 Piramal Business Overview
  28. 8.5.3 Piramal Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio
  30. 8.5.5 Piramal Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 AbbVie
  38. 8.7.1 AbbVie Company Information
  39. 8.7.2 AbbVie Business Overview
  40. 8.7.3 AbbVie Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio
  42. 8.7.5 AbbVie Recent Developments
  43. 8.8 Baxter Healthcare
  44. 8.8.1 Baxter Healthcare Company Information
  45. 8.8.2 Baxter Healthcare Business Overview
  46. 8.8.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio
  48. 8.8.5 Baxter Healthcare Recent Developments
  49. 8.9 B.Braun
  50. 8.9.1 B.Braun Company Information
  51. 8.9.2 B.Braun Business Overview
  52. 8.9.3 B.Braun Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio
  54. 8.9.5 B.Braun Recent Developments
  55. 8.10 Fresenius-Kabi
  56. 8.10.1 Fresenius-Kabi Company Information
  57. 8.10.2 Fresenius-Kabi Business Overview
  58. 8.10.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio
  60. 8.10.5 Fresenius-Kabi Recent Developments
  61. 8.11 China National Medicines Guorui Pharmaceutical Co.,Ltd.
  62. 8.11.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
  63. 8.11.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
  64. 8.11.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio
  66. 8.11.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
  67. 8.12 Hengrui
  68. 8.12.1 Hengrui Company Information
  69. 8.12.2 Hengrui Business Overview
  70. 8.12.3 Hengrui Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio
  72. 8.12.5 Hengrui Recent Developments
  73. 8.13 Nhwa
  74. 8.13.1 Nhwa Company Information
  75. 8.13.2 Nhwa Business Overview
  76. 8.13.3 Nhwa Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio
  78. 8.13.5 Nhwa Recent Developments
  79. 8.14 Lunan Pharmaceutical Group Corporation
  80. 8.14.1 Lunan Pharmaceutical Group Corporation Company Information
  81. 8.14.2 Lunan Pharmaceutical Group Corporation Business Overview
  82. 8.14.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio
  84. 8.14.5 Lunan Pharmaceutical Group Corporation Recent Developments
  85. 8.15 Xi'an Libang
  86. 8.15.1 Xi'an Libang Company Information
  87. 8.15.2 Xi'an Libang Business Overview
  88. 8.15.3 Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio
  90. 8.15.5 Xi'an Libang Recent Developments
  91. 8.16 Yichang Humanwell
  92. 8.16.1 Yichang Humanwell Company Information
  93. 8.16.2 Yichang Humanwell Business Overview
  94. 8.16.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio
  96. 8.16.5 Yichang Humanwell Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Injection General Anesthesia Drugs Value Chain Analysis
  2. 9.1.1 Intravenous Injection General Anesthesia Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Injection General Anesthesia Drugs Sales Mode & Process
  6. 9.2 Intravenous Injection General Anesthesia Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Injection General Anesthesia Drugs Distributors
  9. 9.2.3 Intravenous Injection General Anesthesia Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst